About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

RaQualia Pharma Inc.(4579) Financial Results

4579
TSE Growth
RaQualia Pharma Inc.
369
JPY
-1
(-0.27%)
Dec 23, 3:30 pm JST
2.35
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2020 1,107 -486 -527 -606 -29.0 0 Feb 12, 2021 J-GAAP
Dec, 2021 2,776 707 863 755 36.1 0 Feb 14, 2022 J-GAAP
Dec, 2022 2,918 866 904 723 34.5 0 Feb 14, 2023 J-GAAP
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 Guidance 3,135 -234 -476 -584 -26.7 0 Dec 13, 2024 J-GAAP
YoY +64.9% +30.6% -62.5% -80.8% -78.5%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 2,918 866 904 755 36.1
Fiscal Year Dec, 2022 Dec, 2022 Dec, 2022 Dec, 2021 Dec, 2021
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2021 1,456 393 431 453 21.6 0 Feb 14, 2022 J-GAAP
Jul - Dec, 2022 1,471 315 223 254 12.1 0 Feb 14, 2023 J-GAAP
Jul - Dec, 2023 887 -314 -329 -348 -16.1 0 Feb 14, 2024 J-GAAP
Jul - Dec, 2024 Guidance 1,724 -80 -199 -261 -12.0 0 Dec 13, 2024 J-GAAP
YoY +94.4% +74.5% +39.5% +25.0% +26.0%
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Dec, 2021 707 87 366 -279 -16 2,240 42.80 J-GAAP
Dec, 2022 866 1,433 1,480 -47 -29 3,679 58.80 J-GAAP
Dec, 2023 -337 -853 -718 -135 793 3,664 53.33 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 1,904 501 676 467 22.3 74.8 Nov 11, 2022 J-GAAP
Jan - Sep, 2023 1,495 -108 -36 -117 -5.5 Nov 10, 2023 J-GAAP
Jan - Sep, 2024 2,369 -27 -231 -339 -15.7 Nov 14, 2024 J-GAAP
YoY +58.5% +75.0% -541.7% -189.7% -188.3%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 1,014 365 228 256 12.2 36.0 Feb 14, 2023 J-GAAP
Jan - Mar, 2023 370 -108 -110 -148 -6.9 -29.2 May 15, 2023 J-GAAP
Apr - Jun, 2023 644 85 146 173 8.2 13.2 Aug 10, 2023 J-GAAP
Jul - Sep, 2023 481 -85 -72 -142 -6.6 -17.7 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 406 -229 -257 -206 -9.6 -56.4 Feb 14, 2024 J-GAAP
Jan - Mar, 2024 648 44 -77 -78 -3.6 6.8 May 15, 2024 J-GAAP
Apr - Jun, 2024 763 -198 -200 -245 -11.4 -26.0 Aug 14, 2024 J-GAAP
Jul - Sep, 2024 958 127 46 -16 -0.7 13.3 Nov 14, 2024 J-GAAP
YoY +99.2% +88.7% +88.8%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 1,153 670 751 982 72.5
Fiscal Year Dec, 2021 Jun, 2022 Jun, 2022 Mar, 2014 Mar, 2014
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Dec, 2021 227.97 91.3 5,234 4,777 49 0.01 Feb 14, 2022 J-GAAP
Dec, 2022 261.65 87.7 6,257 5,488 773 0.04 Feb 14, 2023 J-GAAP
Dec, 2023 281.87 88.7 6,871 6,094 449 0.06 Feb 14, 2024 J-GAAP
Jan - Sep, 2024 57.5 9,751 5,610 109 0.64 Nov 14, 2024 J-GAAP